OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial - Wechsler, M; Akuthota, P; Jayne, D; Khoury, P; Klion, A; Langford, C; Merkel, P; Moosig, F; Specks, U; Cid, M; Luqmani, R; Brown, J; et al. (BMJ Publishing Group, 2017)